NaDeNo seeks funding ahead of clinical entry
Nordic Life Science Days
With a base at AstraZeneca’s BioVentureHub, NaDeNo Nanoscience was on home turf when Nordic Life Science Days brought the industry together.
“It’s an exciting stage for the company as the technology moves from preclinical to clinical development,” say Annbjørg Eide Falck and Jens Bjørheim from NaDeNo Nanoscience.

October 23, 2025
